US Contrast Media Market Size, Share & Trend Analysis

New York, April 05, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “US Contrast Media Market Size, Share & Trends Analysis Report By Type, By Application, By Modality And Segment Forecasts, 2022 – 2030” – https://www.reportlinker.com/p06251019/?utm_source=GNW

US contrast media market growth and trends

The US contrast media market is expected to reach USD 3.36 billion by 2030, registering a CAGR of 4.12% over the forecast period. The growing burden of chronic diseases is creating demand for diagnostic imaging procedures, which in turn is driving the growth of the market. Imaging tests, such as MRI, have become an integral part of the diagnosis of most diseases, and the widespread penetration of imaging technology in healthcare has increased the demand for contrast media on the American market. Chronic diseases, such as cancer and diabetes, are rapidly becoming a major public health concern and are among the leading causes of death in the United States, requiring early diagnostic tools and effective treatment options.

Therefore, the increasing prevalence of complex comorbidities and long-term illnesses is a major driver of imaging tests and contrast agents; thus contributing to the growth of the market. The COVID-19 outbreak has negatively impacted the market due to decrease in patient visits to hospitals.

Many radiology departments have seen a rapid decline in the volume of imaging cases. However, many US states have begun to reopen their economies; however, it will take time for the rate of contrast media use to reach pre-pandemic levels. Moreover, with the launch of COVID-19 vaccines and the easing of restrictions, the import and export of raw materials has resumed. This, in turn, is therefore expected to drive the growth of the market over the forecast period.

US Contrast Media Market Report Highlights
• Imaging tests, such as MRI, have become an integral part of the diagnosis of most diseases, and the widespread penetration of imaging technology in healthcare has increased the demand for contrast media in the American market.
• Iodinated-type segment accounted for the largest market share in 2021 due to excellent radiopacity and low toxicity of iodinated contrast media compared to other agents
• The X-ray/CT modality segment held the largest revenue share in 2021. Wide acceptance and profitability of the X-ray/CT modality is driving the adoption of contrast agents for this modality
• Growing demand for imaging procedures has driven extensive R&D activities by contrast media manufacturers to bring new products to market and gain approval for new indications
• For example, in 2021, Bracco obtained US FDA approval for the 20-vial pack configuration of Lumason, which is an ultrasound contrast agent
Read the full report: https://www.reportlinker.com/p06251019/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________


        

Comments are closed.